Literature DB >> 3308669

Conceptual review of the hepatic vascular bed.

W W Lautt1, C V Greenway.   

Abstract

Mesh：

Year:  1987        PMID： 3308669     DOI： 10.1002/hep.1840070527

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  48 in total

1.  Successful embolization therapy for bleeding from jejunal varices after choledochojejunostomy: report of a case.

Authors:  Akitoshi Sasamoto; Junichi Kamiya; Yuji Nimura; Masato Nagino
Journal:  Surg Today       Date:  2010-07-30       Impact factor: 2.549

Review 2.  Regulation of hepatic blood flow: the hepatic arterial buffer response revisited.

Authors:  Christian Eipel; Kerstin Abshagen; Brigitte Vollmar
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

3.  Combined transjugular intrahepatic portosystemic shunt and segmental Lipiodol hepatic artery embolization for the treatment of esophagogastric varices and hepatocellular carcinoma in patients with cirrhosis: preliminary report.

Authors:  H Sakaguchi; H Uchida; M Maeda; N Matsuo; K Kichikawa; H Ohishi; H Nishida; K Ueno; K Nishimine; J Rösch
Journal:  Cardiovasc Intervent Radiol       Date:  1995 Jan-Feb       Impact factor: 2.740

4.  Hepatic perfusion changes after transcatheter arterial embolization (TAE) of hepatocellular carcinoma: measurement by dynamic computed tomography (CT).

Authors:  Y Tsushima; Y Unno; J Koizumi; S Kusano
Journal:  Dig Dis Sci       Date:  1998-02       Impact factor: 3.199

5.  The aging liver. Drug clearance and an oxygen diffusion barrier hypothesis.

Authors:  D G Le Couteur; A J McLean
Journal:  Clin Pharmacokinet       Date:  1998-05       Impact factor: 6.447

6.  Lymph vessel expansion and function in the development of hepatic fibrosis and cirrhosis.

Authors:  B Vollmar; B Wolf; S Siegmund; A D Katsen; M D Menger
Journal:  Am J Pathol       Date:  1997-07       Impact factor: 4.307

7.  Minimizing the inhibitory effect of neutralizing antibody for efficient gene expression in the liver with adeno-associated virus 8 vectors.

Authors:  Jun Mimuro; Hiroaki Mizukami; Shuji Hishikawa; Tomokazu Ikemoto; Akira Ishiwata; Asuka Sakata; Tsukasa Ohmori; Seiji Madoiwa; Fumiko Ono; Keiya Ozawa; Yoichi Sakata
Journal:  Mol Ther       Date:  2012-12-18       Impact factor: 11.454

8.  Automatic annotation of radiological observations in liver CT images.

Authors:  Francisco Gimenez; Jiajing Xu; Yi Liu; Tiffany Liu; Christopher Beaulieu; Daniel Rubin; Sandy Napel
Journal:  AMIA Annu Symp Proc       Date:  2012-11-03

9.  Flushing out antibodies to make AAV gene therapy available to more patients.

Authors:  Steven E Raper; James M Wilson; Frederick A Nunes
Journal:  Mol Ther       Date:  2013-02       Impact factor: 11.454

10.  Lymphatic marker podoplanin/D2-40 in human advanced cirrhotic liver--re-evaluations of microlymphatic abnormalities.

Authors:  Hiroaki Yokomori; Masaya Oda; Fumihiko Kaneko; Shigeyuki Kawachi; Minoru Tanabe; Kazunori Yoshimura; Yuko Kitagawa; Toshifumi Hibi
Journal:  BMC Gastroenterol       Date:  2010-11-08       Impact factor: 3.067
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.